Drug reference
golimumab
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Musculoskeletal (TNF-alpha Inhibitors)
Mechanism of action
Human anti-TNF-alpha monoclonal antibody, binds to both soluble and transmembrane bioactive forms of human TNFα; prevents binding of TNF-alpha to its receptors, thereby inhibiting biological activity of TNFα (a cytokine protein).
Common side effects
- Upper respiratory tract infection
- Injection site reactions
- Dizziness
- Viral infections
- Increased ALT & AST
Known interactions (4)
- golimumab + measles mumps and rubella vaccine Contraindicated
- golimumab + upadacitinib Major
- golimumab + hepatitis a vaccine inactivated Moderate
- golimumab + pneumococcal vaccine 13-valent Moderate
Related conditions
Frequently asked questions
What drug class is golimumab?
golimumab belongs to: Musculoskeletal.
How does golimumab work?
Human anti-TNF-alpha monoclonal antibody, binds to both soluble and transmembrane bioactive forms of human TNFα; prevents binding of TNF-alpha to its receptors, thereby inhibiting biological activity of TNFα (a cytokine protein).
What are the common side effects of golimumab?
Upper respiratory tract infection, Injection site reactions, Dizziness, Viral infections, Increased ALT & AST
Which drugs interact with golimumab?
measles mumps and rubella vaccine, upadacitinib, hepatitis a vaccine inactivated, pneumococcal vaccine 13-valent
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.